Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial-Reference-Cited by-同舟云学术

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

Published:2015-10 Issue:10 Volume:2 Page:e417-e426
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Platzbecker Uwe,Wong Raymond S M,Verma Amit,Abboud Camille,Araujo Sergio,Chiou Tzeon-Jye,Feigert John,Yeh Su-Peng,Götze Katharina,Gorin Norbert-Claude,Greenberg Peter,Kambhampati Suman,Kim Yoo-Jin,Lee Je-Hwan,Lyons Roger,Ruggeri Marco,Santini Valeria,Cheng Gregory,Jang Jun Ho,Chen Chien-Yuan,Johnson Brendan,Bennett John,Mannino Frank,Kamel Yasser Mostafa,Stone Nicole,Dougherty Souria,Chan Geoffrey,Giagounidis Aristoteles

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy;van Lom;Genes Chromosomes Cancer,1999

2. The hematopoietic stem cell in myelodysplasia;Liesveld;Stem Cells,2004

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study;Wandt;Lancet,2012

5. The incidence and impact of thrombocytopenia in myelodysplastic syndromes;Kantarjian;Cancer,2007

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape;Current Oncology;2024-04-03

2. Novel Perspectives on Thrombopoietin Receptor Agonists Applications;Hämostaseologie;2024-03-18

3. Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy;Journal of Thrombosis and Haemostasis;2024-01

4. Next‐generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial;eJHaem;2023-05-22

5. Eltrombopag for tyrosine kinase inhibitors-associated thrombocytopenia in chronic myeloid leukemia;International Journal of Hematology;2023-03-09